Biotia
12 known investors
Biotia develops diagnostic tests and software for infectious disease detection using metagenomic sequencing and AI. The company serves patients, healthcare providers, and hospitals seeking pathogen identification and infection control intelligence.
Founders & leadership
CM
Chris MasonFounder
NO
Niamh O'HaraFounder & CEO
Investors · 12
Cloquet Capital Partners, LLCNew Canaan · $50K – $500K
DigitalDx VenturesMenlo Park
Everywhere VenturesNew York · $250K
Red Bear VenturesIthaca · $200K – $1.3M
SeedToBSuwanee · $500K – $1.5M
Tau VenturesPalo Alto · $500K
Third Act VenturesSan Diegovia Max Zamkow · inferred
Hyperplane Venture CapitalreportedBoston · $250K – $3M
Leawood Venture Capital Llcreported · 2 sourcesLeawood · $1M – $3M
OCA VenturesreportedChicago · $1M – $3M
TAU VenturesreportedTel Aviv · $1M – $28M
The FundreportedAustin · $50K – $250K
In the news
- Biotia Raises $8M to Fight Infectious Diseases Powered by AI & Genomicshitconsultant.net · 2022
- Biotia, Pioneering Pathogen Detection Company, Raises an Oversubscribed $8M Series A | AP Newsapnews.com · 2022
- Biotia Raises $8M in Series A Financing | GenomeWebgenomeweb.com · 2022
- Biotia Raises $2.4M in Seed Financing | GenomeWebgenomeweb.com · 2019